Publication | Closed Access

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Hematological MalignancyLymphoid NeoplasiaMabthera International TrialMedicinePathologyYoung PatientsChop-like ChemotherapyImmunotherapyOncologyRadiation Oncology